Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Antonella Venturino"'
Publikováno v:
Expert Review of Anticancer Therapy. 23:421-429
Autor:
Giuseppe Colloca, Antonella Venturino
Publikováno v:
Pancreas. 50:1131-1136
Systemic inflammatory response (SIR) plays a central role in the prognosis of unresectable or metastatic pancreatic ductal adenocarcinoma (mPDAC), and many SIR-related peripheral blood cell (PBC)-derived variables have been proposed as prognostic fac
Publikováno v:
Clinical Colorectal Cancer. 19:e200-e207
Background Carcinoembryonic antigen (CEA) best reduction after chemotherapy in patients with metastatic colorectal cancer (mCRC) has been reported as a prognostic factor. The study aims to evaluate whether serum CEA kinetics after 8 weeks of chemothe
Publikováno v:
Cancer Immunology, Immunotherapy. 70:1115-1125
Systemic inflammation response (SIR) plays a role in predicting prognosis of patients with metastatic colorectal cancer (mCRC). Chemotherapy-induced neutropenia has been suggested as another evaluable prognostic and predictive factor. This is a retro
Publikováno v:
Surgical oncology. 44
Primary tumor resection (PTR) in patients with metastatic unresectable colorectal cancer is less and less used to prevent local complications. Although its therapeutic effect is debated, poor data are available about the activity of chemotherapy (CHT
Publikováno v:
Clinical Colorectal Cancer. 18:e343-e348
Differently than other patients with advanced tumor, among patients with metastatic colorectal cancer the relationship among systemic inflammation related variables and prognosis is controversial. In this retrospective analysis of 145 patients with m
Publikováno v:
International Journal of Colorectal Disease. 34:657-666
The introduction of new drugs and multimodal treatments for the management of patients with metastatic colorectal cancer (mCRC) has reduced the importance of time-to-event endpoints and reported the attention on the response-related endpoints. Furthe
Survival of patients with metastatic cancer has increased over the past two decades as a result of a progressive improvement of regional and systemic therapies. However, oncologists'estimates of patients'predicted overall survival in metastatic cance
Publikováno v:
International journal of colorectal disease. 36(4)
Many reports suggest more activity of cytotoxic chemotherapy among patients with metastatic colorectal cancer (mCRC) who experience neutropenia, but it is not clear whether this finding is related to drug effect alone. The aim of the study is to iden
Publikováno v:
American Journal of Clinical Oncology. 41:316-320
OBJECTIVES The role of the tumor growth fraction has been investigated poorly in metastatic castration-resistant prostate cancer (mCRPC). The aim of this study was to assess whether some prostate-specific antigen (PSA)-related variables of tumor cell